The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations

Center for Vascular Pathology, Moscow1,000 enrolled

Overview

The aim of this study is to evaluate the efficacy and safety of different phlebotonic drugs in children and to assess patient satisfaction after treatment.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Drug Effect Children, Only Vascular Malformations Surgery

Interventions

DetralexDRUG

Diosmin+ Hesperidin

TroxevasinDRUG

Troxerutin

Eligibility

Sex: ALLMin age: 1 YearMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: venous malformation * venous malformation Exclusion Criteria: * allergy

Locations (1)

The Vascular Anomalies Center (VAC) "Hemangioma" LLC

Moscow, Russia

RECRUITING

Outcomes

Primary Outcomes

Coagulation testing

Time frame: 1 month

Central Contacts

Ekaterina Listovskaia

CONTACT

+79032069027 listovskaya_ek@outlook.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.